Vulvovaginal atrophy (VVA) is a condition frequently observed in menopause. Its symptoms can significantly affect the quality of life of patients. Since VVA is related to estrogen deficiency, chemotherapy and hormone therapy for breast cancer (BC) might cause VVA by inducing menopause. Given the lack of effective treatment for VVA in BC survivors, we retrospectively evaluated the efficacy and tolerability of fractional microablative CO2 laser therapy in these patients.
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study / Pagano, Tiziana; De Rosa, Pasquale; Vallone, Roberta; Schettini, Francesco; Arpino, Grazia; Giuliano, Mario; Lauria, Rossella; DE SANTO, Irene; Conforti, Alessandro; Gallo, Alessandra; Nazzaro, Giovanni; De Placido, Sabino; Locci, Mariavittoria; De Placido, Giuseppe. - In: MENOPAUSE. - ISSN 1072-3714. - (2017), p. 1. [10.1097/GME.0000000000001053]
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study
Pagano, Tiziana;Vallone, Roberta;Schettini, Francesco;Arpino, Grazia;Giuliano, Mario;Lauria, Rossella;DE SANTO, IRENE;Conforti, Alessandro;GALLO, ALESSANDRA;Nazzaro, Giovanni;De Placido, Sabino;Locci, Mariavittoria;De Placido, Giuseppe
2017
Abstract
Vulvovaginal atrophy (VVA) is a condition frequently observed in menopause. Its symptoms can significantly affect the quality of life of patients. Since VVA is related to estrogen deficiency, chemotherapy and hormone therapy for breast cancer (BC) might cause VVA by inducing menopause. Given the lack of effective treatment for VVA in BC survivors, we retrospectively evaluated the efficacy and tolerability of fractional microablative CO2 laser therapy in these patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
